4/3/25 17:00 | 4/1/25 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 554 | 13 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -14 | 4.15 | 0 | -3 | -20 | 13 | D | | | | | | | | | | | | | | |
12/3/24 16:30 | 11/29/24 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 53 | 5 | D | | | | | | | | | | | | | | |
12/3/24 16:30 | 12/2/24 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -3 | 5.64 | 0 | -1 | -9 | 5 | D | | | | | | | | | | | | | | |
6/17/24 19:18 | 6/13/24 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | CA | D | | S | -37 | 3.37 | 0 | -11 | -25 | 33 | D | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 86 | 4 | D | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -6 | 11.45 | 0 | -1 | -12 | 4 | D | | | | | | | | | | | | | | |
6/15/23 21:01 | 6/13/23 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | CA | D | | S | -35 | 3.45 | 0 | -10 | -19 | 44 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 603 | 2 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -12 | 22.10 | 0 | -1 | -20 | 2 | D | | | | | | | | | | | | | | |
2/16/21 16:10 | 2/11/21 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dorval Allison | MA | O | CFO | S | -24 | 7.55 | 0 | -3 | -6 | 46 | D | | | | | | | | | | | | | | |
1/14/21 17:57 | 1/12/21 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dorval Allison | MA | O | CFO | S | -25 | 8.62 | 0 | -3 | -6 | 49 | D | | | | | | | | | | | | | | |
1/29/20 17:27 | 1/21/20 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dorval Allison | MA | O | CFO | S | -42 | 13.36 | 0 | -3 | -11 | 25 | D | | | | | | | | | | | | | | |